These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11170422)

  • 21. Crystallographic analysis of CaaX prenyltransferases complexed with substrates defines rules of protein substrate selectivity.
    Reid TS; Terry KL; Casey PJ; Beese LS
    J Mol Biol; 2004 Oct; 343(2):417-33. PubMed ID: 15451670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptide specificity of protein prenyltransferases is determined mainly by reactivity rather than binding affinity.
    Hartman HL; Hicks KA; Fierke CA
    Biochemistry; 2005 Nov; 44(46):15314-24. PubMed ID: 16285735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reaction path of protein farnesyltransferase at atomic resolution.
    Long SB; Casey PJ; Beese LS
    Nature; 2002 Oct; 419(6907):645-50. PubMed ID: 12374986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel peptide substrates for protein farnesyltransferase reveals two substrate classes with distinct sequence selectivities.
    Hougland JL; Hicks KA; Hartman HL; Kelly RA; Watt TJ; Fierke CA
    J Mol Biol; 2010 Jan; 395(1):176-90. PubMed ID: 19878682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient farnesylation of an extended C-terminal C(
    Blanden MJ; Suazo KF; Hildebrandt ER; Hardgrove DS; Patel M; Saunders WP; Distefano MD; Schmidt WK; Hougland JL
    J Biol Chem; 2018 Feb; 293(8):2770-2785. PubMed ID: 29282289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion of protein farnesyltransferase to a geranylgeranyltransferase.
    Terry KL; Casey PJ; Beese LS
    Biochemistry; 2006 Aug; 45(32):9746-55. PubMed ID: 16893176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective modification of CaaX peptides with ortho-substituted anilinogeranyl lipids by protein farnesyl transferase: competitive substrates and potent inhibitors from a library of farnesyl diphosphate analogues.
    Troutman JM; Subramanian T; Andres DA; Spielmann HP
    Biochemistry; 2007 Oct; 46(40):11310-21. PubMed ID: 17854205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expansion of protein farnesyltransferase specificity using "tunable" active site interactions: development of bioengineered prenylation pathways.
    Hougland JL; Gangopadhyay SA; Fierke CA
    J Biol Chem; 2012 Nov; 287(45):38090-100. PubMed ID: 22992747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substrate binding is required for release of product from mammalian protein farnesyltransferase.
    Tschantz WR; Furfine ES; Casey PJ
    J Biol Chem; 1997 Apr; 272(15):9989-93. PubMed ID: 9092540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Photoaffinity analogues of farnesyl pyrophosphate transferable by protein farnesyl transferase.
    Chehade KA; Kiegiel K; Isaacs RJ; Pickett JS; Bowers KE; Fierke CA; Andres DA; Spielmann HP
    J Am Chem Soc; 2002 Jul; 124(28):8206-19. PubMed ID: 12105898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The chaperone SmgGDS-607 has a dual role, both activating and inhibiting farnesylation of small GTPases.
    García-Torres D; Fierke CA
    J Biol Chem; 2019 Aug; 294(31):11793-11804. PubMed ID: 31197034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analogs of farnesyl diphosphate alter CaaX substrate specificity and reactions rates of protein farnesyltransferase.
    Jennings BC; Danowitz AM; Wang YC; Gibbs RA; Distefano MD; Fierke CA
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1333-6. PubMed ID: 26803203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Farnesyl diphosphate analogues with aryl moieties are efficient alternate substrates for protein farnesyltransferase.
    Subramanian T; Pais JE; Liu S; Troutman JM; Suzuki Y; Leela Subramanian K; Fierke CA; Andres DA; Spielmann HP
    Biochemistry; 2012 Oct; 51(41):8307-19. PubMed ID: 22989235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time-dependent inhibition of protein farnesyltransferase by a benzodiazepine peptide mimetic.
    Roskoski R; Ritchie PA
    Biochemistry; 2001 Aug; 40(31):9329-35. PubMed ID: 11478901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. J-104,871, a novel farnesyltransferase inhibitor, blocks Ras farnesylation in vivo in a farnesyl pyrophosphate-competitive manner.
    Yonemoto M; Satoh T; Arakawa H; Suzuki-Takahashi I; Monden Y; Kodera T; Tanaka K; Aoyama T; Iwasawa Y; Kamei T; Nishimura S; Tomimoto K
    Mol Pharmacol; 1998 Jul; 54(1):1-7. PubMed ID: 9658183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and synthesis of a transferable farnesyl pyrophosphate analogue to Ras by protein farnesyltransferase.
    Chehade KA; Andres DA; Morimoto H; Spielmann HP
    J Org Chem; 2000 May; 65(10):3027-33. PubMed ID: 10814193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein farnesyltransferase: measurement of enzymatic activity in 96-well format using TopCount microplate scintillation counting technology.
    Harwood HJ
    Anal Biochem; 1995 Apr; 226(2):268-78. PubMed ID: 7793628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydrophobicity and functionality maps of farnesyltransferase.
    Ahmed S; Majeux N; Caflisch A
    J Mol Graph Model; 2001; 19(3-4):307-17, 380-7. PubMed ID: 11449569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the carboxyterminal residue in peptide binding to protein farnesyltransferase and protein geranylgeranyltransferase.
    Roskoski R; Ritchie P
    Arch Biochem Biophys; 1998 Aug; 356(2):167-76. PubMed ID: 9705207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted reengineering of protein geranylgeranyltransferase type I selectivity functionally implicates active-site residues in protein-substrate recognition.
    Gangopadhyay SA; Losito EL; Hougland JL
    Biochemistry; 2014 Jan; 53(2):434-46. PubMed ID: 24344934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.